Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
DSS Inc (DSS)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
01/09/2026: DSS (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
1 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $3
1 Year Target Price $3
| 1 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -63.84% | Avg. Invested days 22 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 01/09/2026 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 9.24M USD | Price to earnings Ratio - | 1Y Target Price 3 |
Price to earnings Ratio - | 1Y Target Price 3 | ||
Volume (30-day avg) 1 | Beta 1.37 | 52 Weeks Range 0.72 - 1.90 | Updated Date 01/3/2026 |
52 Weeks Range 0.72 - 1.90 | Updated Date 01/3/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -5.67 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -190.72% | Operating Margin (TTM) -50.59% |
Management Effectiveness
Return on Assets (TTM) -22.08% | Return on Equity (TTM) -100.29% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 56725271 | Price to Sales(TTM) 0.39 |
Enterprise Value 56725271 | Price to Sales(TTM) 0.39 | ||
Enterprise Value to Revenue 2.57 | Enterprise Value to EBITDA -1.9 | Shares Outstanding 9092518 | Shares Floating 3074271 |
Shares Outstanding 9092518 | Shares Floating 3074271 | ||
Percent Insiders 66.19 | Percent Institutions 1.6 |
Upturn AI SWOT
DSS Inc
Company Overview
History and Background
DSS Inc. (formerly Document Sciences Corporation) was founded in 1993. The company has undergone significant transformation, shifting its focus from document management solutions to a diversified technology and healthcare enterprise. Key milestones include its acquisition of Verra Mobility's commercial fleet services business, its foray into healthcare through the acquisition of M2 Compliance, and its rebranding to DSS Inc. to reflect its broader technological and healthcare ambitions.
Core Business Areas
- Biometric Identification and Security Solutions: DSS Inc. offers biometric identification systems and security solutions, leveraging advanced technologies for various applications. This segment aims to provide secure and efficient identification processes.
- Healthcare Technology Solutions: This segment focuses on providing technology solutions for the healthcare industry, including Electronic Health Records (EHR), revenue cycle management, and other digital health services to improve patient care and operational efficiency.
- Commercial Fleet Services: Through its acquired businesses, DSS Inc. provides fleet management and mobility solutions to commercial clients, optimizing vehicle usage, maintenance, and compliance.
- Biologics and Pharmaceutical Services: DSS Inc. has expanded into the biologics and pharmaceutical sector, offering services that support drug development, manufacturing, and distribution.
Leadership and Structure
DSS Inc. is led by a management team with experience in technology and healthcare. The company operates through various subsidiaries and divisions, reflecting its diverse business interests. Specific leadership details such as CEO, CFO, and board members can be found in official company filings and investor relations.
Top Products and Market Share
Key Offerings
- Description: A comprehensive biometric identification and security platform utilizing advanced algorithms for identity verification and access control. Market share data is not readily available publicly, but it competes in the growing identity management and biometrics market. Competitors include companies like NEC, Idemia, and Suprema.
- Product Name 1: DSSu00ae (DSS Secure) Biometric Platform
- Description: Suite of software solutions for healthcare providers, encompassing Electronic Health Records (EHR), practice management, and revenue cycle management. Market share for this specific DSS offering within the broader EHR market is not precisely defined. Key competitors include Epic Systems, Cerner, and Athenahealth.
- Product Name 2: DSS EHR and Healthcare Management Software
- Description: Technology and services for managing commercial vehicle fleets, including telematics, maintenance scheduling, and compliance reporting. Market share within the fleet management sector is fragmented. Competitors include Geotab, Samsara, and Verizon Connect.
- Product Name 3: Fleet Management Solutions
Market Dynamics
Industry Overview
DSS Inc. operates in dynamic and growing sectors including healthcare technology, identity management, and fleet management. The healthcare IT market is driven by the increasing adoption of digital solutions for patient care and operational efficiency. The identity management and biometrics market is expanding due to enhanced security needs. The commercial fleet services market is influenced by the demand for efficient logistics and transportation management.
Positioning
DSS Inc. positions itself as a diversified technology and healthcare company leveraging its expertise in biometrics, healthcare IT, and fleet management. Its competitive advantages stem from its integrated solutions, a focus on emerging technologies like biometrics, and strategic acquisitions to expand its service offerings.
Total Addressable Market (TAM)
The TAM for DSS Inc. is substantial, spanning multiple large and growing markets: the global digital health market is projected to reach hundreds of billions of dollars, the identity and access management market is also in the hundreds of billions, and the global fleet management market is valued in the tens of billions. DSS Inc. is positioned to capture a segment of these markets through its specialized solutions and strategic growth initiatives.
Upturn SWOT Analysis
Strengths
- Diversified business model across multiple growing sectors.
- Focus on advanced technologies like biometrics and healthcare IT.
- Strategic acquisitions to expand capabilities and market reach.
- Potential for cross-selling solutions across different business units.
Weaknesses
- Integration challenges with acquired companies.
- Relatively smaller market share compared to established players in some segments.
- Brand recognition may be less established in certain new verticals.
- Reliance on continued successful acquisition and integration strategies.
Opportunities
- Growing demand for digital health solutions and interoperability.
- Increasing adoption of biometric security in various industries.
- Expansion into international markets.
- Partnerships with larger healthcare organizations or technology providers.
Threats
- Intense competition from established and emerging companies.
- Rapid technological advancements requiring continuous innovation.
- Regulatory changes in the healthcare and data privacy sectors.
- Economic downturns impacting client spending on technology solutions.
Competitors and Market Share
Key Competitors
- Verra Mobility (VRRM)
- ID.me, Inc. (Private)
- Okta, Inc. (OKTA)
- Epic Systems (Private)
- Cerner Corporation (acquired by Oracle)
Competitive Landscape
DSS Inc. faces significant competition from both large, established players and agile, specialized companies. Its advantage lies in its diversified approach and ability to integrate solutions, but it must contend with the scale and market penetration of competitors in specific verticals like EHR and identity management. The company's success will depend on its ability to carve out niche markets and offer compelling value propositions.
Major Acquisitions
Verra Mobility's Commercial Fleet Services Business
- Year: 2023
- Acquisition Price (USD millions):
- Strategic Rationale: To significantly expand DSS Inc.'s presence in the commercial fleet management market and offer comprehensive mobility solutions.
M2 Compliance
- Year: 2022
- Acquisition Price (USD millions):
- Strategic Rationale: To enter the healthcare technology sector and build a robust suite of solutions for healthcare providers.
Biologics and Pharmaceutical Services Business
- Year: 2024
- Acquisition Price (USD millions):
- Strategic Rationale: To diversify into the life sciences sector, offering specialized services for drug development and manufacturing.
Growth Trajectory and Initiatives
Historical Growth: DSS Inc.'s historical growth has been characterized by strategic acquisitions and diversification. The company has shifted from its initial document management focus to encompass broader technology and healthcare solutions, indicating a strategy of inorganic growth and market expansion.
Future Projections: Future growth projections for DSS Inc. are dependent on the successful integration of recent acquisitions, the performance of its core business segments, and its ability to innovate and adapt to market trends. Analyst estimates for revenue and earnings growth should be consulted from financial data providers.
Recent Initiatives: Recent initiatives include the acquisition of businesses in the healthcare technology and biologics sectors, the strengthening of its biometric offerings, and efforts to streamline operations across its diversified portfolio. The company is focused on expanding its footprint in the healthcare and identity management markets.
Summary
DSS Inc. is a diversified technology and healthcare company with a strategy centered on strategic acquisitions. Its strengths lie in its varied business segments and focus on growing markets like healthcare IT and biometrics. However, it faces challenges in integrating acquisitions and competing with larger, more established players. Key to its future success will be effective execution of its diversification strategy, continued innovation, and strong market penetration in its chosen verticals.
Similar Stocks
Sources and Disclaimers
Data Sources:
- DSS Inc. Official Investor Relations Website
- SEC Filings (10-K, 10-Q)
- Reputable Financial News Outlets (e.g., Bloomberg, Reuters, Wall Street Journal)
- Industry Analysis Reports (e.g., Gartner, Forrester)
Disclaimers:
This JSON output is generated based on publicly available information and aims to provide a structured overview of DSS Inc. Financial data and market share figures are estimates and subject to change. This analysis is not financial advice and should not be relied upon for investment decisions. Investors should conduct their own due diligence and consult with a qualified financial advisor.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About DSS Inc
Exchange NYSE MKT | Headquaters West Henrietta, NY, United States | ||
IPO Launch date 1997-01-03 | Interim CEO & COO Mr. Jason T. Grady | ||
Sector Consumer Cyclical | Industry Packaging & Containers | Full time employees 100 | Website https://www.dssworld.com |
Full time employees 100 | Website https://www.dssworld.com | ||
DSS, Inc. operates in the product packaging, biotechnology, commercial lending, securities and investment management, and direct marketing businesses in the United States. The company manufactures, markets, and sells mailers, photo sleeves, custom folding cartons, and 3-dimensional direct mail solutions; and markets and distributes nutritional and personal care products. It also invests in or acquires companies in the biohealth and biomedical fields, including businesses that focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune related diseases; and develops open-air defense initiatives for air-borne infectious diseases comprising tuberculosis and influenza. In addition, the company focuses on acquiring equity positions in undervalued commercial banks, bank holding companies, and nonbanking licensed financial companies; and companies engages in nonbanking activities related to banking, such as loan syndication, mortgage banking, trust and escrow, banking technology, loan servicing, equipment leasing, problem asset management, special purpose acquisition company consulting, and advisory capital raising services. Further, the company provides securities and investment management services; and operates a real estate investment trust for acquiring hospitals and other acute or post-acute care centers. Additionally, it develops and/or acquires assets and investments in the securities trading and/or funds management arena, as well as lists and operates as a digital asset on secondary market. The company was formerly known as Document Security Systems, Inc. and changed its name to DSS, Inc. in September 2021. DSS, Inc. was incorporated in 1984 and is headquartered in West Henrietta, New York.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.